| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |